Class I · High risk
Velocity Pharma brand Lubricating Eye Drop
Non-Sterility
FDA Drug Recalls
231 recalls · Class I, newest first
Class I · High risk
Leader brand Lubricant Eye Drops
Non-Sterility
Class I · High risk
Target brand High Performance Lubricant Eye Drops
Non-Sterility
Class I · High risk
Leader brand Dry Eye Relief
Non-Sterility
Class I · High risk
CVS Health brand
Non-Sterility
Class I · High risk
Leader brand Eye Irritation Relief
Non-Sterility
Class I · High risk
CVS brand Multi Action Relief Drops
Non-Sterility
Class I · High risk
Leader brand Dry Eye Relief
Non-Sterility
Class I · High risk
CVS Health brand Lubricating Gel Drops
Non-Sterility
Class I · High risk
Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops
Non-Sterility
Class I · High risk
CVS Health brand Lubricant Eye Drops
Non-Sterility
Class I · High risk
Leader brand Lubricant Eye Drops
Non-Sterility
Class I · High risk
CVS Health brand Lubricant Eye Drops
Non-Sterility
Class I · High risk
Dr. Ergin's SugarMD
MARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburide
Class I · High risk
LEADER brand Lubricant Eye Drops
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk
LEADER brand Dry Eye Relief
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk
LEADER brand Lubricant Eye Drops
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk
LEADER brand Lubricant Eye Drops
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk
LEADER brand Dry Eye Relief
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk
LEADER brand Eye Irritation Relief
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk
Kuka Flex Forte caplets
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Class I · High risk
Reumo Flex caplets
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Class I · High risk
Artri King Reforzado con Origa y Omega 3 tablets
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Class I · High risk
ELCYS (cysteine hydrochloride injection)
Presence of Particulate Matter: Silicone
Class I · High risk
Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL
Presence of Particulate Matter: Silicone